Skip to content
★ Sign in to follow
JB

James B. Wyngaarden

Idera Pharmaceuticals, Inc.
Total declarations
18
Company
1
▲ Purchases (7 ops.)
€20k
▼ Sales (5 ops.)
€197k

Latest filing published 16 Jun 2008 for Idera Pharmaceuticals, INC., €12k.

Insider track record

Disclosed buys
7
Disclosed sells
5
Signal history

No signal scores available.

Closed purchases

Market purchases
7

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

James B. Wyngaarden: trading record in brief

This profile gathers the share dealings of James B. Wyngaarden in Idera Pharmaceuticals, Inc. Between 5 April 2006 and 12 June 2008, the trades on record add up to 18 filings.

Both buying and selling appear: 7 purchases worth €20k, against 5 sales worth €197k. Netting one side against the other leaves €177k of net selling. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 1 share grant and 5 option exercises. Since January 2008: 1 purchase and 5 sales on the market.

A typical purchase (the median) is worth €2,661.

On 1 July 2008 came the latest disclosure, a share grant for €3,567 in Idera Pharmaceuticals, Inc. The clock since the last published purchase (4 January 2008) now reads 6,884 days. The median gap between a trade and its publication by SEC (Form 4) is 3 days. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to James B. Wyngaarden

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations17 total

17 of 17 declarations